Stilla Technologies, based in Paris, offers advanced solutions in genetic analysis, outpacing traditional methods. Their focus on cutting-edge technology addresses the need for accuracy and advancement in genetic data. Operating on a B2B model, they partner with enterprises to enhance research speed and precision. Backed by Eurazeo, Stilla Technologies is positioned for growth and shows strong potential to lead in areas constrained by slower, less accurate traditional tools.